文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

一名11岁KRAS基因突变患者的早发性结直肠癌及多处转移:病例报告

Early-Onset Colorectal Adenocarcinoma and Multiple Metastases in an 11-Year-Old Patient With KRAS Mutation: A Case Report.

作者信息

Rezazadeh Mohammad, Kheradpishe Ahmadreza, Kamyabi Amirreza, Shateri Amiri Bahareh, Faranoush Mohammad

机构信息

Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences (IUMS), Tehran, IRN.

Internal Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences (IUMS), Tehran, IRN.

出版信息

Cureus. 2025 Mar 26;17(3):e81235. doi: 10.7759/cureus.81235. eCollection 2025 Mar.


DOI:10.7759/cureus.81235
PMID:40291278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12026210/
Abstract

Early-onset colorectal cancer (EO-CRC), defined as colorectal adenocarcinoma diagnosed before age 50, is increasing globally, with distinct clinicopathologic and molecular features compared to adult-onset disease. While risk factors such as genetic mutations and lifestyle influences are implicated, pediatric cases remain exceptionally rare. This report presents a unique case of colorectal adenocarcinoma with multiple metastases in an 11-year-old patient, contributing critical insights into the molecular pathogenesis and diagnostic challenges of EO-CRC in pediatric populations. Furthermore, the aggressive nature of this disease underscores significant treatment challenges, ranging from limited evidence-based therapeutic protocols for young patients to variable responses to multimodal therapies, resulting in a generally poor prognosis.

摘要

早发性结直肠癌(EO-CRC)定义为50岁之前诊断出的结直肠腺癌,在全球范围内呈上升趋势,与成人发病的疾病相比具有独特的临床病理和分子特征。虽然基因突变和生活方式等风险因素与之相关,但儿科病例仍然极为罕见。本报告介绍了一例11岁患者患有多发转移的结直肠腺癌的独特病例,为儿科人群中EO-CRC的分子发病机制和诊断挑战提供了重要见解。此外,这种疾病的侵袭性突出了重大的治疗挑战,从针对年轻患者的循证治疗方案有限到对多模式疗法的反应不一,导致总体预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4931/12026210/d73c37234cdd/cureus-0017-00000081235-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4931/12026210/376f41af6fbd/cureus-0017-00000081235-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4931/12026210/d73c37234cdd/cureus-0017-00000081235-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4931/12026210/376f41af6fbd/cureus-0017-00000081235-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4931/12026210/d73c37234cdd/cureus-0017-00000081235-i02.jpg

相似文献

[1]
Early-Onset Colorectal Adenocarcinoma and Multiple Metastases in an 11-Year-Old Patient With KRAS Mutation: A Case Report.

Cureus. 2025-3-26

[2]
Colorectal Cancer Brain Metastasis With Concomitant KRAS and BRAF Mutations: A Case Report.

Cureus. 2024-9-9

[3]
EARLY-ONSET COLORECTAL CANCER: AN ELEVEN-YEAR ANALYSIS OF CLINICOPATHOLOGICAL CHARACTERISTICS AT A TERTIARY HEALTHCARE CENTER.

Arq Gastroenterol. 2023

[4]
Early-onset colorectal cancer: A review of current knowledge.

World J Gastroenterol. 2023-2-28

[5]
Trends in epidemiology, clinicopathological characteristics and survival outcomes among patients with synchronous early-onset colorectal liver metastases in the United States from 2010 to 2019.

Transl Gastroenterol Hepatol. 2025-4-17

[6]
Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.

Mod Pathol. 2012-4-6

[7]
Prognostic Differences Between Early-Onset and Late-Onset Colorectal Cancer.

Medicina (Kaunas). 2025-2-24

[8]
Clinicopathological and mutational differences between tumors with multiple metastases and single lung metastasis in colorectal cancer.

Oncol Lett. 2020-7

[9]
High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis.

Hum Pathol. 2016-10

[10]
Unique clinicopathologic and genetic alteration features in early onset colorectal carcinoma compared with age-related colorectal carcinoma: a large cohort next generation sequence analysis.

Hum Pathol. 2020-11

本文引用的文献

[1]
Genomic and Transcriptomic Analysis of a Patient with Early-Onset Colorectal Cancer and Therapy-Induced Focal Nodular Hyperplasia: A Case Report.

J Pers Med. 2024-6-15

[2]
Survival outcome and prognostic factors for early-onset and late-onset metastatic colorectal cancer: a population based study from SEER database.

Sci Rep. 2024-2-22

[3]
KRAS Sequence Variation as Prognostic Marker in Patients With Young- vs Late-Onset Colorectal Cancer.

JAMA Netw Open. 2023-11-1

[4]
Risk factors for early-onset colorectal cancer: systematic review and meta-analysis.

Front Oncol. 2023-5-5

[5]
KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China.

Medicine (Baltimore). 2023-3-3

[6]
Correlation between , and mutations and tumor localizations in patients with primary and metastatic colorectal cancer.

Arch Med Sci. 2021-3-24

[7]
KRAS Gene Copy Number as a Negative Predictive Biomarker for the Treatment of Metastatic Rectal Cancer With Cetuximab: A Case Report.

Front Oncol. 2022-5-26

[8]
Pediatric Colorectal Carcinoma: A Series of Seven Cases.

J Indian Assoc Pediatr Surg. 2022

[9]
The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection.

Lancet Gastroenterol Hepatol. 2022-3

[10]
An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report.

Front Oncol. 2021-11-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索